Catalyst Magazine: Gene therapy’s second wave

In retrospect, the 1990s appear to have been gene therapy’s lost decade. Then, the idea that common diseases could be cured by repairing underlying defects in our genetic information had probably become too appealing. New cures seemed just around the corner. During the ’90s, researchers launched more than 400 clinical trials. This rush was driven by the blossoming of the biotechnology industry and the growing political clout of patient-advocacy organizations…